US, EU and UK Antitrust Enforcers Form Pharma Monitoring Taskforce
AZ’s planned Alexion acquisition may be an early target
Antitrust regulators in the US, Europe and elsewhere say they will now collaborate on how to best assess pharmaceutical mergers, in a move that could restrict deals on grounds they excessively raise prices paid by consumers or dampen medical innovation.
